We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: COVID-19 antivirals largely prescribed to over-70s in Australia, finds research
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > COVID-19 antivirals largely prescribed to over-70s in Australia, finds research
COVID-19 antivirals largely prescribed to over-70s in Australia, finds research
Health

COVID-19 antivirals largely prescribed to over-70s in Australia, finds research

Last updated: February 11, 2025 6:15 am
Editorial Board Published February 11, 2025
Share
SHARE

Credit score: Pixabay from Pexels

5 years on from the beginning of the pandemic, with its worldwide lockdowns and border closures, new knowledge has revealed a manner of monitoring waves of COVID-19, and suggests one staple of pandemic life continues to be very a lot wanted.

An examination of three.8 million affected person information from common practices throughout NSW and Victoria in 2022–23 has proven simply over 3% of sufferers have been prescribed oral COVID-19 antivirals, however that quantity was increased for older age teams.

The research revealed within the Australian Journal of Major Well being, by researchers from the Australian Institute of Well being Innovation at Macquarie College, analyzed routinely collected, de-identified session and prescription info from 938 common practices between March 2022 and September 2023.

Two oral COVID-19 antivirals have been authorized to be used in Australia in January 2022, and have been added to the Pharmaceutical Advantages Scheme in March and Could 2022 respectively.

Initially, eligibility was restricted to sufferers with specified danger components, together with age, dwelling in residential aged care, or having sure well being situations. These have been expanded throughout 2022–23.

The research’s senior creator, Professor Andrew Georgiou, says the analysis was undertaken to have a look at gaps within the information round how oral COVID-19 antivirals have been being prescribed on the whole observe, together with affected person demographics and the position performed by telehealth.

“Greater understanding of the uptake of oral COVID-19 antivirals can help inform future directions for eligibility criteria, provide a better comprehension of the characteristics of patients receiving treatment, and identify demands on general practice,” he says.

“Out of our pattern, 3.39% of sufferers aged 15 years and older have been prescribed antivirals, however that rose to 14.79% of these aged 70 and older, with the 80 to 84 age group being the probably to obtain prescriptions.

“They were more likely to be prescribed to females than males, to people in Victoria than those in NSW, and to those in higher socioeconomic groupings.”

The vast majority of sufferers who have been prescribed antivirals solely obtained one prescription within the 19-month research interval, with simply over 7% receiving a couple of prescription.

Sufferers with continual situations—significantly cardiovascular and musculoskeletal situations—have been additionally extra more likely to obtain antivirals, which gives vital insights into well being traits of sufferers looking for the remedy.

Monitoring waves and the significance of telehealth

Professor Georgiou says month-to-month prescribing volumes additionally aligned with COVID-19 waves.

“At the height of the pandemic, it was mandatory to report a positive COVID-19 test result, and this fed into state and federal health department data, which was vital for disease tracking,” he says. “That knowledge is now not collected, however COVID continues to flow into in the neighborhood.

“Our results suggest that in its absence, we can use the volume of oral COVID-19 antivirals being prescribed by GPs as another indicator of periods of increased transmission.”

One other key discovering was that telehealth was used for greater than 54% of consultations the place COVID-19 antivirals have been prescribed.

Professor Georgiou says this reveals continued entry to telehealth is required for COVID-positive sufferers, because it permits major well being care groups to supply time-critical care whereas decreasing their publicity to the SARS-CoV-2 virus.

Extra info:
Judith Thomas et al, Oral COVID-19 antiviral prescribing in Australian common observe – a retrospective observational research, Australian Journal of Major Well being (2025). DOI: 10.1071/PY24170

Supplied by
Macquarie College

Quotation:
COVID-19 antivirals largely prescribed to over-70s in Australia, finds research (2025, February 10)
retrieved 11 February 2025
from https://medicalxpress.com/information/2025-02-covid-antivirals-70s-australia.html

This doc is topic to copyright. Other than any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.

You Might Also Like

Clinically deployed AI steerage might stop C. difficile unfold

Experimental mannequin for myelodysplastic syndromes uncovers genetic alterations to enhance characterization

AI device analyzes blood DNA fragments for quicker, inexpensive most cancers monitoring

Extreme use of disinfectants in intensive care sufferers could increase threat of antibiotic-resistant infections

What does the brand new pandemic treaty imply for world well being?

TAGGED:antiviralsAustraliaCOVID19findsover70sprescribedstudy
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Mets fail to brush White Sox in all-around tough 9-4 loss at wet Citi Discipline
Sports

Mets fail to brush White Sox in all-around tough 9-4 loss at wet Citi Discipline

Editorial Board May 28, 2025
Ingrid Lewis-Martin, who resigned as chief adviser to Mayor Adams, expects to be indicted in coming days
Why will we desire curves over straight edges? Researchers probe mind for clues
‘The Final of Us’ Season 2, Episode 6: The foundation of Ellie’s anger and estrangement
A brand new device may help predict brain-damaging seizures and liberate steady EEG machines for high-risk sufferers

You Might Also Like

New PET imaging method offers exact mapping of nasopharyngeal most cancers biomarker
Health

New PET imaging method offers exact mapping of nasopharyngeal most cancers biomarker

June 14, 2025
Muscle ‘management middle’ discovery might assist aged with higher muscle therapeutic
Health

Muscle ‘management middle’ discovery might assist aged with higher muscle therapeutic

June 14, 2025
Two biomarkers that will predict diabetic foot ulcer therapeutic outcomes recognized
Health

Two biomarkers that will predict diabetic foot ulcer therapeutic outcomes recognized

June 14, 2025
First knowledge from the EULAR RheumaFacts mission
Health

First knowledge from the EULAR RheumaFacts mission

June 14, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?